ID: ALA5186926

Max Phase: Preclinical

Molecular Formula: C73H125N11O35S

Molecular Weight: 1748.91

Associated Items:

Representations

Canonical SMILES:  COc1ccc(S(=O)(=O)N(CCCCCCNC(=O)CCCCC(=O)NCCN(CCC(=O)NCCNC(=O)CCCCC(=O)NCCO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)CCC(=O)NCCNC(=O)CCCCC(=O)NCCO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)CC(=O)NO)cc1

Standard InChI:  InChI=1S/C73H125N11O35S/c1-111-43-18-20-44(21-19-43)120(109,110)84(38-57(97)82-108)32-11-3-2-10-24-74-49(89)12-4-7-15-52(92)79-29-35-83(33-22-55(95)77-27-25-75-50(90)13-5-8-16-53(93)80-30-36-112-70-66(106)62(102)68(47(41-87)116-70)118-72-64(104)60(100)58(98)45(39-85)114-72)34-23-56(96)78-28-26-76-51(91)14-6-9-17-54(94)81-31-37-113-71-67(107)63(103)69(48(42-88)117-71)119-73-65(105)61(101)59(99)46(40-86)115-73/h18-21,45-48,58-73,85-88,98-108H,2-17,22-42H2,1H3,(H,74,89)(H,75,90)(H,76,91)(H,77,95)(H,78,96)(H,79,92)(H,80,93)(H,81,94)(H,82,97)/t45-,46-,47-,48-,58+,59+,60+,61+,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72+,73+/m1/s1

Standard InChI Key:  IAPGYEXCZBOFIX-POHNHZBWSA-N

Associated Targets(Human)

Matrix metalloproteinase 13 4133 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Galectin-1 387 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Galectin-3 545 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Galectin-3 98 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Galectin-1 6 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1748.91Molecular Weight (Monoisotopic): 1747.8060AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Manning JC, Baldoneschi V, Romero-Hernández LL, Pichler KM, GarcÍa Caballero G, André S, Kutzner TJ, Ludwig AK, Zullo V, Richichi B, Windhager R, Kaltner H, Toegel S, Gabius HJ, Murphy PV, Nativi C..  (2022)  Targeting osteoarthritis-associated galectins and an induced effector class by a ditopic bifunctional reagent: Impact of its glycan part on binding measured in the tissue context.,  75  [PMID:36327696] [10.1016/j.bmc.2022.117068]

Source